Many probiotic organisms lose viability during manufacturing, storage and passage through the digestive system, reducing the dose that reaches the gut.
R&D Focus
Probiotic encapsulation and delivery technology.
Innovative Solution
MELLO develops delivery technology intended to protect probiotics and improve the amount that reaches its intended site of action.
Investment Funding
Last Funding Stage
Convertible Note
Total Funding Amount
548.38K
Last Funding Date
16-03-2023
Lead Investors
BioInnovation Institute, BioInnovation Institute Venture House
About
MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics. The company aims to overcome a number of industry-wide challenges which currently prevent optimizing probiotic benefits.
Products
Product
Probiotic delivery technology for manufacturers developing microbiome products.
Demo Product or Complete Product?
Research and product-development stage.
Something missing or incorrect on this page? Help us enrich this information
